Exhibitor News
- 2024-02-21
LAUNCHED INTO ORBIT ON SPACEX FALCON 9, THE HIGH-PRECISION LASER MEASUREMENT DEVICE FOR FIBRE OPTICS
LAUNCHED INTO ORBIT ON SPACEX FALCON 9, THE HIGH-PRECISION LASER MEASUREMENT DEVICE FOR FIBRE OPTICS
- 2024-02-07
PharmaLegacy Labs, a Shanghai pre-clinical CRO, recently formed a strategic alliance with Pasadena’s BioVinc. Both companies have expertise in musculoskeletal drug development. BioVinc has developed a bone targeting platform based on its bisphosphonate research. It sells off-the-shelf and custom probes for bone disease, while also developing its own innovative drugs.
PharmaLegacy Labs, a Shanghai pre-clinical CRO, recently formed a strategic alliance with Pasadena’s BioVinc. Both companies have expertise in musculoskeletal drug development. BioVinc has developed a bone targeting platform based on its bisphosphonate research. It sells off-the-shelf and custom probes for bone disease, while also developing its own innovative drugs.
Exhibitor News
- 2024-02-21
LAUNCHED INTO ORBIT ON SPACEX FALCON 9, THE HIGH-PRECISION LASER MEASUREMENT DEVICE FOR FIBRE OPTICS
LAUNCHED INTO ORBIT ON SPACEX FALCON 9, THE HIGH-PRECISION LASER MEASUREMENT DEVICE FOR FIBRE OPTICS
- 2024-02-07
PharmaLegacy Labs, a Shanghai pre-clinical CRO, recently formed a strategic alliance with Pasadena’s BioVinc. Both companies have expertise in musculoskeletal drug development. BioVinc has developed a bone targeting platform based on its bisphosphonate research. It sells off-the-shelf and custom probes for bone disease, while also developing its own innovative drugs.
PharmaLegacy Labs, a Shanghai pre-clinical CRO, recently formed a strategic alliance with Pasadena’s BioVinc. Both companies have expertise in musculoskeletal drug development. BioVinc has developed a bone targeting platform based on its bisphosphonate research. It sells off-the-shelf and custom probes for bone disease, while also developing its own innovative drugs.
Tel: +86 21 6157 7217
Email: Linc.Cai@informa.com